Septic shock. Special problems of disease and therapy in childhood
Schippan, R.
Kinderarztliche Praxis 46(4): 203-210
1978
ISSN/ISBN: 0023-1495 PMID: 661077 Document Number: 124760
Document emailed within 1 workday
Related Documents
Barron, R.L. 1993: Pathophysiology of septic shock and implications for therapy Clinical Pharmacy 12(11): 829-845Costa, P.P.; Pierri, A.; Fernandes, P.; Piccinni, P. 1979: Hemodynamic data and their use in therapy of septic shock Minerva Anestesiologica 45(3): 139-146
Nuñez-Cornejo, C.; Borrás-Blasco, J.; Gracia-Perez, A.; Rosique-Robles, J.D.; Lopez-Camps, V.; Casterã, E.; Abad, F.J. 2008: Septic shock and community-acquired pneumonia associated with etanercept therapy International Journal of Clinical Pharmacology and Therapeutics 46(4): 193-197
Wise, W.C.; Halushka, P.V.; Knapp, R.G.; Cook, J.A. 1985: Ibuprofen, methylprednisolone, and gentamicin as conjoint therapy in septic shock Circulatory Shock 17(1): 59-71
Gendzwiłł, A. 2007: Reactive oxygen species and vascular hyporeactivity in septic shock. Part II--scavengers and vascular hyporeactivity in septic shock Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 23(136): 284-287
Pedersen, M.Østergaard.; Pedersen, D.Sonne.; Pedersen, M.; Penkowa, M. 2008: Neisseria meningitidis. The pathophysiological role of lipopolysaccharides in association with meningococcal disease and septic shock Ugeskrift for Laeger 170(6): 421-426
Offner, F.; Philippé, J.; Vogelaers, D.; Colardyn, F.; Baele, G.; Baudrihaye, M.; Vermeulen, A.; Leroux-Roels, G. 1990: Serum tumor necrosis factor levels in patients with infectious disease and septic shock Journal of Laboratory and Clinical Medicine 116(1): 100-105
Zecca, G.; Del Curto, E.; Manzoni, C. 1993: The persistence after clinical recovery and the suspension of therapy of altered ESR values in a case of meningococcal sepsis and septic shock Minerva Pediatrica 45(3): 123-126
Zhou, X.; Liu, D.; Long, Y.; Mei, D.; Chai, W.; Rui, X.; Wang, X.; Wang, H.; Zhang, Q.; Guo, H.; Li, Z.; Li, X. 2014: Prognostic outcomes of adherence to guideline of bundle therapy by key points of control strategies in septic shock patients Zhonghua Yi Xue Za Zhi 94(13): 994-998
Haywood, G.A.; Tighe, D.; Moss, R.; al-Saady, N.; Foshola, T.O.; Riley, S.P.; Pearson, I.; Webb, A.; McKenna, W.J.; Bennett, E.D. 1991: Goal directed therapy with dobutamine in a porcine model of septic shock: effects on systemic and renal oxygen transport Postgraduate Medical Journal 67(Suppl 1): S36
Goto, Y. 1979: Microcirculatory changes during endotoxin shock: application of Shwartzman reaction as a septic shock model Masui. Japanese Journal of Anesthesiology 28(9): 914-921
Lillehei, R.C.; Dietzman, R.H.; Motsay, G.J.; Schultz, L.S.; Romero, L.H.; Beckman, C.B. 1972: The pharmacologic approach to the treatment of shock. I. Defining traumatic, septic, and cardiogenic shock Geriatrics 27(7): 73-83
Mojzes, L.; Dosa, E.; Foldes, V.; Kiss, L. 1989: The differential diagnosis of the septic shock and toxic shock syndromes Acta Medicinae Legalis et Socialis 39(1): 251-257
Tahara, H.; Katoh, Y.; Yano, H.; Kanbara, N.; Kohri, K.; Kurita, T. 1993: Septic shock induced by extracorporeal shock wave lithotripsy treatment with percutaneous nephrostomy in 5 cases with urolithiasis Hinyokika Kiyo. Acta Urologica Japonica 39(12): 1119-1124
Yussof, S.Jahan.Mohd.; Zakaria, M.Idzwan.; Mohamed, F.Laham.; Bujang, M.Adam.; Lakshmanan, S.; Asaari, A.Hassan. 2012: Value of Shock Index in prognosticating the short-term outcome of death for patients presenting with severe sepsis and septic shock in the emergency department Medical Journal of Malaysia 67(4): 406-411
Fuller, L.M.; Gamble, J.F. 1973: Updated Hodgkin's disease. C. Advanced disease and special problems. Combined chemotherapy-radiotherapy program JAMA 223(2): 168-169
Schamaun, M.; Bernhardt, D. 1972: Severe diffuse lung changes with marked functional shunt after hemorrhagic and septic shock (shock lung) Helvetica Chirurgica Acta 39(1): 177-182
DeWitt, D.E.; Ostergaard, D. 1983: Traveling with lung disease. The special problems and concerns Postgraduate Medicine 74(5): 333-334
Wallin, J.D. 1987: Refractory hypertension: patient types, special problems, and approaches to therapy Journal of the National Medical Association 79 Suppl: 9-12
Horner, J.; Massey, E.W. 1991: Managing dysphagia. Special problems in patients with neurologic disease Postgraduate Medicine 89(5): 203-6 211-3